Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection. | Front Mol Biosci | 2023 | 37325475 | PubTator, text mining | PubMed |
| Advancement in COVID-19 detection using nanomaterial-based biosensors. | Exploration (Beijing) | 2023 | 37323622 | PubTator, text mining | PubMed |
| Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design. | RSC Adv | 2023 | 37323463 | PubTator, text mining | PubMed |
| Expression of Envelope Protein Encoded by Endogenous Retrovirus K102 in Rheumatoid Arthritis Neutrophils. | Microorganisms | 2023 | 37317284 | PubTator, text mining | PubMed |
| Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves. | Microorganisms | 2023 | 37317262 | PubTator, text mining | PubMed |
| Overview of Diagnostic Methods, Disease Prevalence and Transmission of Mpox (Formerly Monkeypox) in Humans and Animal Reservoirs. | Microorganisms | 2023 | 37317160 | PubTator, text mining | PubMed |
| Harnessing aptamers against COVID-19: A therapeutic strategy. | Drug Discov Today | 2023 | 37315763 | PubTator, text mining | PubMed |
| In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2. | Inform Med Unlocked | 2023 | 37305192 | PubTator, text mining | PubMed |
| COVID-19 Therapeutic Potential of Natural Products. | Int J Mol Sci | 2023 | 37298539 | PubTator, text mining | PubMed |
| SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? | Int J Mol Sci | 2023 | 37298304 | PubTator, text mining | PubMed |
| Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches. | Front Cell Infect Microbiol | 2023 | 37293206 | PubTator, text mining | PubMed |
| Viral proteogenomic and expression profiling during productive replication of a skin-tropic herpesvirus in the natural host. | PLoS Pathog | 2023 | 37289833 | PubTator, text mining | PubMed |
| Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors. | Nat Commun | 2023 | 37280206 | PubTator, text mining | PubMed |
| Development of a universal real-time RT-PCR assay for detection of pan-SARS-coronaviruses with an RNA-based internal control. | Front Microbiol | 2023 | 37275136 | PubTator, text mining | PubMed |
| In vitro and in vivo efficacy of Molnupiravir against Zika virus infections. | Virol Sin | 2023 | 37268161 | PubTator, text mining | PubMed |
| In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19. | Pharmaceuticals (Basel) | 2023 | 37259437 | PubTator, text mining | PubMed |
| Immunoinformatics Vaccine Design for Zika Virus. | Methods Mol Biol | 2023 | 37258930 | PubTator, text mining | PubMed |
| Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year. | PLoS One | 2023 | 37252922 | PubTator, text mining | PubMed |
| 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates. | Mol Ther Nucleic Acids | 2023 | 37251693 | PubTator, text mining | PubMed |
| An overview on medicinal plants used for combating coronavirus: Current potentials and challenges. | J Agric Food Res | 2023 | 37251276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=21